Abstract
Data on the impact of liver disease (LD) in patients with atrial fibrillation (AF) and the role of oral anticoagulant (OAC) drugs for stroke prevention are limited. A retrospective observational population-based cohort study on the administrative health databases of Lombardy region Italy. All AF patients ≥40 years admitted to hospital from 2000 to 2018 were considered. Atrial fibrillation and LD diagnosis were established using ICD9-CM codes. Use of OAC was determined with Anatomical Therapeutic Chemical codes. Primary study outcomes were stroke, major bleeding, and all-cause death. Among 393 507 AF patients, 16 168 (4.1%) had concomitant LD. Liver disease AF patients were significantly less treated with OAC. Concomitant LD was associated with an increased risk in all the study outcomes [hazard ratio (HR): 1.18, 95% confidence interval (CI): 1.11-1.25 for stroke; HR: 1.57, 95% CI: 1.47-1.66 for major bleeding; HR: 1.41, 95% CI: 1.39-1.44 for all-cause death]. Use of OAC in patients with AF and LD resulted in a reduction in stroke (HR: 0.80, 95% CI: 0.70-0.92), major bleeding (HR: 0.86, 95% CI: 0.74-0.99), and all-cause death (HR: 0.77, 95% CI: 0.73-0.80), with similar results according to subgroups. A net clinical benefit (NCB)...Continue Reading
References
Dec 1, 1996·Journal of Clinical Epidemiology·W D'HooreC Tilquin
Sep 19, 2009·Chest·Gregory Y H LipHarry J G M Crijns
Mar 20, 2010·Chest·Ron PistersGregory Y H Lip
Apr 20, 2010·Blood·Ton Lisman, Robert J Porte
Jul 2, 2011·Journal of Hepatology·F VioliA K Burroughs
Jul 15, 2011·The New England Journal of Medicine·Armando Tripodi, Pier Mannuccio Mannucci
Feb 7, 2012·BMC Family Practice·Victoria L BaczekCraig I Coleman
Jul 24, 2012·Gastroenterology·Erica VillaDominique Valla
Dec 3, 2014·International Journal of Cardiology·Seung-Jun LeeBoyoung Joung
Jan 9, 2015·European Journal of Internal Medicine·Xingshun QiDaiming Fan
Apr 12, 2016·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver (EASL)UNKNOWN European Association for the Study of Obesity (EASO)
May 24, 2016·Journal of Hepatology·Giovanni TargherCorrado Barbui
Oct 30, 2016·Thrombosis and Haemostasis·Gregory Y H LipMelissa Hamilton
Nov 2, 2016·The American Journal of Gastroenterology·Armando TripodiStephen H Caldwell
Dec 27, 2016·Diabetes & Metabolic Syndrome·Toufik Mahfood HaddadVenkata M Alla
May 10, 2017·Gastroenterology·Lorenzo LoffredoFrancesco Violi
Jun 10, 2017·Thrombosis and Haemostasis·Gregory LipTatjana S Potpara
Jun 25, 2017·Journal of the American Heart Association·Ling KuoShih-Ann Chen
Feb 9, 2018·Oncotarget·Jianping HuJun Li
May 12, 2018·Journal of the American College of Cardiology·Arman QamarRobert P Giugliano
Aug 1, 2015·JACC. Clinical Electrophysiology·Stefano FumagalliUNKNOWN EORP-AF Investigators
Jul 22, 2018·International Journal of Cardiology·Irene MarzonaMaria Carla Roncaglioni
Dec 31, 2018·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Ronpichai ChokesuwattanaskulWisit Cheungpasitporn
Mar 2, 2019·Journal of the American College of Cardiology·Eric P StahlLaurence S Sperling
Mar 19, 2019·Journal of Clinical Gastroenterology·Kexin ZhengXingshun Qi
Apr 1, 2019·BMJ Open·Miklos RohlaPaulus Kirchhof
Apr 30, 2019·The Canadian Journal of Cardiology·Marco ProiettiGregory Y H Lip
Jun 28, 2019·Internal and Emergency Medicine·Irene MarzonaMaria Carla Roncaglioni
Jun 30, 2019·Journal of the American College of Cardiology·So-Ryoung LeeGregory Y H Lip
Jun 30, 2019·Journal of the American College of Cardiology·Elaine M Hylek, Frank A Anania
Nov 2, 2019·Mayo Clinic Proceedings·Marco ProiettiAlessandro Nobili